Medtronic PLC
F:2M6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Medtronic PLC (2M6) under the Base Case is 88.41 EUR per share.
Compared with the current market price of 93.48 EUR, the stock appears
Overvalued by 5% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Medtronic Does
Medtronic is one of the world’s largest makers of medical devices. It designs and sells equipment doctors use to treat heart disease, diabetes, spine problems, neurological disorders, and other serious conditions. Its products include pacemakers, insulin pumps, surgical tools, and implantable devices that help manage chronic illness or support surgery.
- Headquarters
- Ireland IE
- Employees
- 95 000
- IPO date
- Nov 21, 1977
Medtronic has a narrow economic moat
Patented device designs and the time needed to learn and replace connected medical systems make it harder for rivals to take Medtronic’s customers. These protections are strongest in complex implants and surgical equipment, rather than across every product it sells. Established competitors still offer alternatives in many of its markets.
Read the full moat analysis
Revenue & Expenses Breakdown
Medtronic PLC
Earnings Waterfall
Medtronic PLC
What is the Intrinsic Value of one 2M6 stock?
The intrinsic value for Medtronic PLC (2M6) under the Base Case is 88.41 EUR.
Is 2M6 stock undervalued or overvalued?
Compared with the current market price of 93.48 EUR, the stock appears Overvalued by 5% .
